Analysis of GSP Follow-up Inspections in Guangdong Province after the Implementation of the New Drug Administration Law of the People's Republic of China

Huang Bingsheng, Li Zhuoxiang, Zhang Zheng, Wu Shengqi

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (6) : 646-657.

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (6) : 646-657. DOI: 10.16153/j.1002-7777.2021.06.006
Quality Management

Analysis of GSP Follow-up Inspections in Guangdong Province after the Implementation of the New Drug Administration Law of the People's Republic of China

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 35(6): 646-657 https://doi.org/10.16153/j.1002-7777.2021.06.006

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/